Clinical Trial

Progesterone Luteal Support in Unexplained Infertility Management

Study acronym: PLUIM
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate whether progesterone in women with unexplained infertility can increases live birth rate. The main research question is: Does luteal phase support with progesterone increase the live birth rate among couples with unexplained infertility? The study compares progesterone with placebo to determine the effectiveness of progesterone in unexplained infertility. Study participants will: * Perform home ovulation tests and maintain a digital diary to record menstrual cycles and study medication use.10 * Take progesterone or placebo twice daily during the luteal phase of each menstrual cycle for up to six months.11 * Continue usual medical care. No additional hospital visits or invasive procedures are required as part of the study.
Trial Details
NCT Number NCT07738068
Lead Sponsor Simone Broer
Collaborators: ZonMw: The Netherlands Organisation for Health Research and Development
Conditions Infertility, Female Infertility, Subfertility, Infertility Primary, Infertility Secondary, Subfertility, Female
Enrollment 640 participants
Start Date 2026-08-01
Primary Completion 2030-08-01 (estimated)
Study Completion 2031-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30